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licenseAtrial fibrillation and dementia: Do risk factors matter?Atrial fibrillation (AF) is the most common sustained car-
diac arrhythmia encountered in clinical practice. The preva-
lence of AF steadily rises with increasing age. Up to 10% of
people age  80 years suffer from this arrhythmia, and it is
estimated that the number of elderly patients with AF will
triple in the next 20 years.1 Similar to AF, one of the most
prevalent neurological disorders is dementia. Worldwide, ~40
million people have dementia, and this number is expected to
increase, owing to an aging population.2 Although the exact
pathophysiological mechanisms of dementia are largely
unknown, there is abundant evidence implicating car-
diovascular disease and its risk factors.3 In this regard, com-
mon conditions associated with aging and AF, such as
diabetes, hypertension, hyperlipidemia, heart failure, obesity,
sleep apnea, and smoking may also predispose individuals to
developing dementia.
Multiple studies have demonstrated the association
between AF and dementia. Ott and colleagues4 were the first
to describe this risk of dementia, in the Rotterdam study. The
estimated odds ratio (OR) of dementia in patients with AF
was 2.3 [95% confidence interval (CI): 1.2e3.4]. However,
the cross-sectional design of this study prevented the authors
from making conclusions regarding a causal relationship.
Since then, several longitudinal studies5e9 and systemic
reviews10,11 have confirmed the associations of AF with
dementia. In a population-based, longitudinal study, de
Bruijn et al9 found that the presence of AF was associated
with an increased risk of dementia in younger (< 67 years)
people. Furthermore, the same group also found that the
duration of AF was significantly associated with the devel-
opment of dementia in younger but not in elderly patients. In
a semisystematic review, Udompanich et al11 found that, in
cross-sectional studies, patients with AF had a 1.7e3.3
greater risk of cognitive impairment and a 2.3-fold increased
risk of dementia, compared with patients in sinus rhythm.
Furthermore, AF is significantly associated not only with
vascular dementia (VaD), but also with Alzheimer’s
dementia (AD) and other forms of dementia.8 In a cohort of
37,025 patients, Bunch et al8 found that, in an age-based
analysis, AF was significantly associated independently
with all dementia types during the 5-year follow-up. Thex.doi.org/10.1016/j.jcma.2016.05.001
901/Copyright © 2016, the Chinese Medical Association. Published by El
(http://creativecommons.org/licenses/by-nc-nd/4.0/).highest risk was in the younger group (< 70 years old). In
addition, the presence of AF was associated with a markedly
increased risk of mortality.
Given these observations, what are the etiology and
potential pathogenic mechanisms underlying dementia in
patients with AF? As previously noted, common vascular risk
factors, such as age, sex, hypertension, diabetes, heart failure,
and hyperlipidemia, were prevalent in both patients with AF
and those with dementia. Of these, hypertension is the most
important risk factor. AF is often the result of hypertensive
heart disease. Both hypertension and AF are also important
risk factors of stroke and related cerebrovascular disorders.
Therefore, one possible explanation of the association of AF
and dementia is that both are the end-stage symptoms of the
systemic disease process of hypertension that gradually
increases vascular stiffness and impairs end-organ micro-
vascular function. The triple insult of stroke, cerebral micro-
bleeding, and non-uniform cerebral blood flow during AF
would therefore substantially increase the risk of dementia in
this group.12
Compared with the general population, patients with AF
have a five-fold increased relative risk of stroke. Loss of
cortical matter from stroke is likely to result in impairment of
memory and cognitive abilities. Elderly patients are more
vulnerable to dementia from stroke, due to the lower cortical
volume in these patients. Furthermore, there is increasing
evidence to show that, in addition to clinically overt stroke, AF
patients also have a higher rate of silent stroke than those in
sinus rhythm.
How about the association between AF and AD in which
prior strokes are excluded? It is possible that the dementia
associated with AF is on a spectrum related to repetitive cer-
ebral injuries, ranging from macroevents (i.e., VaD) to
microevents (AD with chronic volume loss).13 The association
of cerebral microvascular injury with AD was confirmed by an
autopsy study.13 The authors found that this kind of injury was
a common root mechanism that stemmed from cerebral athe-
rosclerosisdsilent, previously undetected lacunar infarcts, and
microemboli. Small repetitive vascular injuries are believed to
be a common cause of white matter lesions that are linked to
cognitive impairment in patients with AF.sevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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eases, variability in pulse and cerebral perfusion pressure in
AF may also play an important role in the development of
dementia. Hypoperfusion of the brain in patients with AF
has been theorized to be at the core of leukoaraiosis or
white matter changes, and the resulting impairment of the
ability of flowing blood to remove microemboli from the
vessels, which results in embolic infarcts. Therefore, if the
variance in R-R interval explains the association between
AF and dementia, what about the burden of ectopic heart
beats? Frequent variance in R-R intervals and cerebral
perfusion pressure may explain, in part, the association
between AF and dementia.13 Normalizing R-R intervals and
treatment approaches might impact risk and improve
function.
If AF is linked to the development of cognitive impair-
ment and dementia, then, what are the risk factors of
dementia, and how can one predict its occurrence among
Asian patients with AF? The CHADS2 and CHA2DS2VASc
scores have recently been increasingly used to guide antith-
rombotic therapy for stroke prevention in AF patients. In
addition to AF, several components of these scores, such as
older age, hypertension, heart failure, and diabetes, are also
important risk factors for dementia, as mentioned previously.
Given this, could these scores predict the occurrence of
dementia? In a nationwide, population-based cohort study,
Liao et al14 found that patients with AF possessed a higher
risk of dementia, with a hazard ratio (HR) of 1.420. The
CHADS2 and CHA2DS2VASc scores were significant pre-
dictors of dementia, with an adjusted HR of 1.520 and 1.497
per each single increment of the CHADS2 and CHA2DS2-
VASc scores, respectively. Therefore, could these scores be
useful for risk stratification with regard to dementia occur-
rence among patients with AF?
In this issue of the Journal of the Chinese Medical Asso-
ciation, Chou et al15 reported on the occurrence and risk
stratification of dementia in patients with AF. In an analysis
of the National Health Insurance Research Database, the
authors found that, of the 15,430 patients with AF, there was
a mean CHADS2 score of 2.73 ± 1.63 and no dementia ini-
tially, and 1135 patients developed dementia (241 VaD and
894 AD) during a mean follow-up period of 3.71 ± 2.78
years. Compared with patients without dementia, patients
with AF and dementia were older (77.37 ± 8.01 years vs.
69.54 ± 13.1 years, p < 0.001) and had a higher incidence of
vascular risk factors, such as hypertension, coronary artery
disease, previous history of stroke/transient ischemic attack,
and chronic kidney disease. Furthermore, the risk of devel-
oping dementia was associated with an increasing CHADS2
score over time, whether patients developed VaD or AD. In
multivariate analysis, an increase by one point in the
CHADS2 score was independently associated with a 54%
increase in the risk of VaD (HR 1.54; 95% confidence
interval 1.41e1.69, p < 0.001) and a 40% increase in AD
(HR 1.40; 95% confidence interval 1.34e1.46, p < 0.001).
This study demonstrated that the CHADS2 score is a usefulpredictor for the development of all types of dementia in
patients with AF. Further, large prospective studies are nee-
ded to confirm the feasibility of the CHADS2 score in the
prediction and management of developing dementia in
patients with high-risk AF.
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